Psoriatic arthritis
The multimillion dollar question for inflammatory arthritis prescriptions is: which drug should I use next?
Drs. Jack Cush & Arthur Kavanaugh, two of rheumatology’s most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the 2025 ACR Convergence meeting in Chicago.
Dr. John Cush RheumNow
3 months ago
Psoriatic Arthritis Imaging
Dr. Arthur Kavanaugh talks about imaging in psoriatic arthritis at #ACR25
https://t.co/l6MKTgEJXu https://t.co/sKhoQWCPli
Nouf Al hemmadi NoufAhmedAlham2
3 months ago
GLP-1 Receptor Agonists in PsA: Mortality and MACE https://t.co/GtTGHY7j5g
@synovialjoints discussed TriNetX data base looking at GLP-1 medications effect on MACE in PsA patients.
@RheumNow
#ACR25
Janet Pope Janetbirdope
3 months ago
What happens if you have #axSpA & concomitant #FM?
Pts with both have less TNFi retention,
-residual pain may lead to d/c Rx.
Need to determine if axSpA pt has #fibromyalgia as there may not be objective findings if no peripheral arthritis in axSpA.
#ACR25 @RheumNow abst#534
A new player is entering the IL-23 arena — and it’s a tablet! Icotrokinra (ICO), a first-in-class peptide that binds and blocks the interleukin-23 receptor (IL-23R), is showing encouraging efficacy and safety across a range of psoriasis (PSO) and psoriatic disease (PsD) studies.
Poster Hall